Clinically node-negative breast cancer, internal mammary lymph nodes, and sentinel lymph node biopsy

Clinical Nuclear Medicine

Volumn 33, Issue 6, 2008, Pages 391-393

  Ramsay, Stuart C ^a,b,d   Cassidy, Nathan ^a   Meade, Sally ^b,c  

^a Department of Medical Physics   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c North Queensland Minimally Invasive Surgery   (Australia)

^d Mater Hospital   (Australia)

Author keywords

Breast cancer; Metastasis; Sentinel lymph node biopsy

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER STAGING; CASE REPORT; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MASTECTOMY; RADIOISOTOPE DISTRIBUTION; SENTINEL LYMPH NODE BIOPSY; BREAST TUMOR; IMAGE ENHANCEMENT; INTRALESIONAL DRUG ADMINISTRATION; LABORATORY DIAGNOSIS; LYMPH NODE; METHODOLOGY; PATHOLOGY; SCINTISCANNING;

ADULT; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRALESIONAL; LYMPH NODES; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 46349106820     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318170d569     Document Type: Article

References (15)

1. Newman EA, Newman LA. Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin North Am. 2007;87:353-364.
2. Uren RF, Howman-Giles RB, Chung DKV, et al. The clinical importance of lymphoscintigraphy for sentinel lymph node biopsy in melanoma and breast cancer. World J Nucl Med. 2006;5(suppl 1):S379-S382.
3. Tuttle TM. Technical advances in sentinel lymph node biopsy for breast cancer. Am Surg. 2004;70:407-413.
4. Uren RF, Howman-Giles RB, Chung D, et al. Role of lymphoscintigraphy for selective sentinel lymphadenectomy. In: Leong SPL, Kitagawa Y, Kitajima M, eds. Selective Sentinel Lymphadenectomy for Human Solid Cancer. New York: Springer; 2005:15-38.
5. Ozmen V, Cabioglu N. Sentinel lymph node biopsy for breast cancer: current controversies. Breast J. 2006;12(suppl 2):S134-S142.
6. Cassidy N, Ramsay SC, Meade S, et al. Preoperative breast lymphoscintigraphy and extra-axillary nodal drainage-a review of the peritumoral injection technique. Ann Surg Oncol. 2008;15:35.
7. Halsted WS. A clinical and histological study of certain adenocarcinomata of the breast. Ann Surg. 1898;28:557-576.
8. Stibbe E. The internal mammary lymphatic glands. J Anat. 1918;52: 257-259.
9. Klauber-DeMore NJ. Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg. 2001;193:547-555.
10. Mansel RE, Fallowfield L, Kissin M, et al. Randomised multicentre trial of sentinel bode biopsy versus the standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599-609.
11. Ting ACC, Cumarasingam B, Szeto E. Successful internal mammary visualization with periareolar injections of Tc-99m antimony sulfur colloid in sentinel node breast lymphoscintigraphy. Clin Nucl Med. 2006;31:593-597.
12. Leong SPL. Paradigm shift of staging and treatment for early breast cancer in the sentinel node era. Breast J. 2006;12(suppl 2):S128-S133.
13. Galimberti V, Veronesi P, Arnone P, et al. Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol. 2002;9:924-928.
14. Singletary SE, Greene FL. Revision of breast cancer staging: the 6th edition of the TNM classification. Semin Surg Oncol. 2003;21:53-59.
15. Breast Section of the Royal Australasian College of Surgeons: sentinel node biopsy in breast cancer. 2005. Available at: http://www.nbcc.org.au/media/ Sentinel-node-biopsy.html. Accessed January 31, 2008.